Paris, France, May 03, 2017 --(PR.com
)-- Cardiology is the field of science which is related to heart. It deals with functions and disorders connected with blood, arteries and veins. The global cardiology market constitutes cardiac biomarkers, interventional cardiology and cardiovascular devices. It found that the global market for in vitro diagnostic tests for cardiac biomarkers was estimated at $3.1 billion in 2012 and nearly $4 billion in 2013. This market is predicted to reach $7.2 billion by 2018, at a compound annual growth rate (CAGR) of 12.8% over the five-year period from 2013 to 2018. And the global market for emerging medical device technologies should reach $90.8 billion by 2021 from $55.9 billion in 2016 at a compound annual growth rate (CAGR) of 10.2%, from 2016 to 2021.
The 18th Annual Cardiologists Conference is going to be held in Paris, France during June 19-21, 2017, revolving around the theme: “Building and Beating to the Future of the Heart.” This meeting has been CME Certified by the Spanish Society of Cardiology Accreditation Committee (CASEC) and they are providing 16 CME Credits to all the participants of this event. As we all know, Paris is known as the “City of Love,” therefore this meeting will also provide an opportunity to the attendees for exploring the city with exciting tourist attractions. This meeting will be fulfilled by the participation of eminent cardiologists, cardiac surgeons, cardio-thoracic surgeons, cardiac nurses, scientists, professors, medical students and business professionals from pharmaceutical companies from every corner of the world so that they can discuss their ideas and deliver their respective research works amongst others.
Cardiologists 2017 will provide exposure to the on-going researches in Cardiology and related science fields. It will also provide insight to the novel inventions and techniques. It is very beneficial for the student Cardiologists and fellowship owners because it provides 16 CME credits which encourage discussions, provide networking opportunities, offer practical experience, explain new or modified regulations and give chance to introduce new ideas and approaches. It also gives opportunities to the companies to showcase their products and have face to face meetings with scientists which help them to increase their business opportunities. Cardiologists 2017 also gives companies to know about their market competitors. Cardiovascular disorder is a major risk factor for cardiovascular diseases, cerebrovascular events and ischemic heart diseases, therefore one of the most important preventable causes of premature morbidity and mortality in developed and developing countries. It is often symptomless, so screening is vital before damage is done. Many surveys continue to show that Cardiac Disorder remains underdiagnosed, undertreated and poorly controlled. Blood Pressure has a skewed normal distribution within the population and the currently accepted model assumes risk is continuously related to BP.
The few main topics of the event are- Heart Diseases, Hypertension, Electrocardiography, Pediatric & Geriatric Cardiology, Interventional Cardiology, Cardio-oncology, Diabetes & Heart, Cardio-thoracic Surgery, Cardiac Nursing and many more.
For further details, please go through: http://annualmeeting.conferenceseries.com/cardiologists/
The Organizing Committee Members of this esteem event comprises- Prof. Guy Hugues Fontaine of La Salpêtrière Hospital, France, Dr. Roland Hetzer, Former Medical Director of German Heart Institute, Germany, Dr. Heinz-Peter Schultheiss, CEO of IKDT, Germany and many more.
Email: firstname.lastname@example.org; email@example.com